Mandatory pharmacist-led education session for patients seeking medical cannabis

The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis pro...

Full description

Saved in:
Bibliographic Details
Published inPharmacy practice Vol. 18; no. 4; p. 2088
Main Authors Parihar, Vikas, Katz, Laura, Siyam, Mahmoud A, Rogers, Anna, Patterson, Lisa, Zacharias, Ramesh
Format Journal Article
LanguageEnglish
Published Spain Centro de Investigaciones y Publicaciones Farmaceuticas 01.10.2020
Centro de Investigaciones y Publicaciones Farmacéuticas
Subjects
Canada
Cannabis
Chronic Pain
Educational Measurement
Medical Marijuana
Original Research
Patient Education as Topic
Patient Preference
Pharmacists
Pharmacology & Pharmacy
Surveys and Questionnaires
Canada
Cannabis
Medical Marijuana
Educational Measurement
Surveys and Questionnaires
Patient Preference
Pharmacists
Chronic Pain
Patient Education as Topic
Online AccessGet full text

Cover

Abstract The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
AbstractList Objective: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. Methods: A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. Results: Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). Conclusions: Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
Objective: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. Methods: A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. Results: Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). Conclusions: Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
OBJECTIVEThe primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. METHODSA retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. RESULTSOf the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). CONCLUSIONSPharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.
Author Patterson, Lisa
Parihar, Vikas
Siyam, Mahmoud A
Zacharias, Ramesh
Rogers, Anna
Katz, Laura
AuthorAffiliation University of Waterloo
Michael G. DeGroote Pain Clinic
McMaster University
AuthorAffiliation_xml – name: McMaster University
– name: Michael G. DeGroote Pain Clinic
– name: University of Waterloo
Author_xml – sequence: 1
  givenname: Vikas
  orcidid: 0000-0002-3369-5908
  surname: Parihar
  fullname: Parihar, Vikas
  email: parihav@mcmaster.ca
  organization: BSc(Pharm), PharmD. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Anesthesia, McMaster University. Hamilton, ON (Canada). parihav@mcmaster.ca
– sequence: 2
  givenname: Laura
  orcidid: 0000-0003-2679-2862
  surname: Katz
  fullname: Katz, Laura
  email: Laura.katz.121@gmail.com
  organization: PhD, CPsych. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Psychology, Neuroscience and Behavior, McMaster University. Hamilton, ON (Canada). Laura.katz.121@gmail.com
– sequence: 3
  givenname: Mahmoud A
  orcidid: 0000-0003-1630-3922
  surname: Siyam
  fullname: Siyam, Mahmoud A
  email: siyammahmoud@gmail.com
  organization: BSc. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & School of Pharmacy, University of Waterloo. Waterloo, ON (Canada). siyammahmoud@gmail.com
– sequence: 4
  givenname: Anna
  orcidid: 0000-0002-1332-339X
  surname: Rogers
  fullname: Rogers, Anna
  email: roganna@hhsc.ca
  organization: BSc(Pharm). Michael G. DeGroote Pain Clinic, Hamilton Health Sciences. Hamilton, ON (Canada). roganna@hhsc.ca
– sequence: 5
  givenname: Lisa
  orcidid: 0000-0002-4134-717X
  surname: Patterson
  fullname: Patterson, Lisa
  email: Lisa.Patterson@niagarahealth.on.ca
  organization: BA. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences. Hamilton, ON (Canada). Lisa.Patterson@niagarahealth.on.ca
– sequence: 6
  givenname: Ramesh
  orcidid: 0000-0003-4337-3416
  surname: Zacharias
  fullname: Zacharias, Ramesh
  email: zacharias@mcmaster.ca
  organization: MD, FRSC, DAAPM, CMD. Michael G. DeGroote Pain Clinic, Hamilton Health Sciences, & Department of Anesthesia, McMaster University. Hamilton, ON (Canada). zacharias@mcmaster.ca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33343771$$D View this record in MEDLINE/PubMed
BookMark eNpVUk1v1DAQtVARLaV_AXLkksWfiSMhpKqCUqmIFRSJm2VP7K2XrL3YCVL_fZ3dpbA-eEbjeW_GM-8lOgkxWITeELwgUvDu3fJep80yaRgXFFO84MVI-QydESmbmjVCnOx8UTec_jxFFzl7g4VoJOVEvkCnjDHO2pacoeUXHXo9xvRQbWdWDT6P9WD7yvYT6NHHUGVb8MW6mKptCdkw5hK0v3xYVRvbe9BDBToEbXx-hZ47PWR7cbDn6Menj3dXn-vbr9c3V5e3NYhWjLUgxFHgtAHDup5hDNLJjsjGGUcbIxvsCHQcW2lcw2hn2pLqDKGWth3wnp2jmz1vH_VabZPf6PSgovZqF4hppXQaPQxWGQ26AyGls46bjklrXS-hOAASS1a43h-4vB6CHY_pDrEp-OTjWiub1eW3O4wx4VxwgQt8sYdn8HaIah2nFMrf1fd5B2rewbymcvh8yQL4sAdsJ1PmB2WgSQ9HVY9fgr9Xq_hHtS2jlJBC8PZAkOLvyeZRbXwGOww62DhlRXlLRFmxaEtqu0-FFHNO1j2VIVjt5KT-yUnNfSquZjkV5Ov_u3zC_RUPewQRIstY
CitedBy_id crossref_primary_10_1007_s40596_024_01943_5
crossref_primary_10_1186_s42238_021_00092_y
ContentType Journal Article
Copyright Copyright: © Pharmacy Practice and the Authors.
Copyright: © Pharmacy Practice and the Authors 2020
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
Copyright_xml – notice: Copyright: © Pharmacy Practice and the Authors.
– notice: Copyright: © Pharmacy Practice and the Authors 2020
– notice: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
– notice: LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
DBID NPM
AAYXX
CITATION
7X8
5PM
GPN
AGMXS
FKZ
DOA
DOI 10.18549/PharmPract.2020.4.2088
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
SciELO
Dialnet (Open Access Full Text)
Dialnet
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef

MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1886-3655
EndPage 2088
ExternalDocumentID oai_doaj_org_article_baca9c588fef4b938eefd8c938cc8083
oai_dialnet_unirioja_es_ART0001445450
S1885_642X2020000400008
10_18549_PharmPract_2020_4_2088
33343771
Genre Journal Article
GroupedDBID ALIPV
NPM
04C
29O
2WC
36B
3V.
53G
5VS
635
6PF
7X7
AAWTL
AAYXX
ADBBV
ADOJX
AFKRA
AFPKN
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APOWU
AZFZN
BAWUL
BCNDV
BENPR
BMSDO
BPHCQ
BVXVI
CITATION
DIK
EBD
EBS
ECF
ECT
EIHBH
EJD
FYUFA
GROUPED_DOAJ
HYE
KQ8
M48
MK0
M~E
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RDY
RIG
RPM
RSK
SCD
Z7D
7X8
5PM
GPN
8AO
8FI
8FJ
ABUWG
ADRAZ
AGMXS
CCPQU
FKZ
HMCUK
IPNFZ
UKHRP
ID FETCH-LOGICAL-c575t-511f2c426cb39d300c8f89186fbf26b860f1c940e8bf6329b726cfb12e279c4d3
IEDL.DBID RPM
ISSN 1885-642X
1886-3655
IngestDate Tue Oct 22 15:15:01 EDT 2024
Thu Jun 27 07:32:01 EDT 2024
Fri Oct 18 20:53:32 EDT 2024
Tue Sep 17 21:12:16 EDT 2024
Fri Jun 28 13:59:13 EDT 2024
Thu Sep 12 16:26:28 EDT 2024
Sun Jun 23 00:32:00 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Canada
Cannabis
Medical Marijuana
Educational Measurement
Surveys and Questionnaires
Patient Preference
Pharmacists
Chronic Pain
Patient Education as Topic
Language English
License Copyright: © Pharmacy Practice and the Authors.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c575t-511f2c426cb39d300c8f89186fbf26b860f1c940e8bf6329b726cfb12e279c4d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2679-2862
0000-0002-3369-5908
0000-0002-4134-717X
0000-0002-1332-339X
0000-0003-1630-3922
0000-0003-4337-3416
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732211/
PMID 33343771
PQID 2471534357
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_baca9c588fef4b938eefd8c938cc8083
dialnet_primary_oai_dialnet_unirioja_es_ART0001445450
scielo_journals_S1885_642X2020000400008
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7732211
proquest_miscellaneous_2471534357
crossref_primary_10_18549_PharmPract_2020_4_2088
pubmed_primary_33343771
PublicationCentury 2000
PublicationDate 2020-10-01
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Spain
PublicationPlace_xml – name: Spain
PublicationTitle Pharmacy practice
PublicationTitleAlternate Pharm Pract (Granada)
PublicationYear 2020
Publisher Centro de Investigaciones y Publicaciones Farmaceuticas
Centro de Investigaciones y Publicaciones Farmacéuticas
Publisher_xml – name: Centro de Investigaciones y Publicaciones Farmaceuticas
– name: Centro de Investigaciones y Publicaciones Farmacéuticas
References Lucas, P 2017; 14
Cox, C 2018; 122
Dattani, S; Mohr, H 2018; 152
Fitzcharles, MA; Shir, Y; Häuser, W 2019; 191
Goldstone, LW; Saldaña, SN; Werremeyer, A 2015; 72
Hill, KP; George, TP 2019; 6
Blevins, CE; Walker, DD; Stephens, RS; Banes, KE; Roffman, RA 2018; 76
Heckman, CJ; Egleston, BL; Hofmann, MT 2010; 19
Zhang, LR; Morgenstern, H; Greenland, S; Chang, SC; Lazarus, P; Teare, MD; Woll, PJ; Orlow, I; Cox, B; Brhane, Y; Liu, G; Hung, RJ 2015; 136
Grotenhermen, F 2003; 42
Seamon, MJ; Fass, JA; Maniscalco-Feichtl, M; Abu-Shraie, NA 2007; 64
Carlini, EA; Cunha, JM 1981; 21
Naftali, T; Mechulam, R; Marii, A; Gabay, G; Stein, A; Bronshtain, M; Laish, I; Benjaminov, F; Konikoff, FM 2017; 62
Hyoguchi, N; Kobayashi, D; Kubota, T; Shimazoe, T 2016; 21
Piper, BJ; DeKeuster, RM; Beals, ML; Cobb, CM; Burchman, CA; Perkinson, L; Lynn, ST; Nichols, SD; Abess, AT 2017; 31
Zvonarev, V; Fatuki, TA; Tregubenko, P 2019; 11
Ravi, D; Ghasemiesfe, M; Korenstein, D; Cascino, T; Keyhani, S 2018; 168
Kritikos, V; Armour, CL; Bosnic-Anticevich, SZ 2007; 44
Hartman, RL; Brown, TL; Milavetz, G; Spurgin, A; Gorelick, DA; Gaffney, G; Huestis, MA 2015; 61
Lough, S 2015; 187
Walus, AN; Woloschuk, DMM 2017; 70
Hawley, P; Gobbo, M; Afghari, N 2020; 20
Wu, TC; Tashkin, DP; Djahed, B; Rose, JE 1988; 318
Kolodny, A; Courtwright, DT; Hwang, CS; Kreiner, P; Eadie, JL; Clark, TW; Alexander, GC 2015; 36
Hines, LA; Freeman, TP; Gage, SH; Zammit, S; Hickman, M; Cannon, M; Munafo, M; MacLeod, J; Heron, J 2020; 77
Bhattacharyya, S; Morrison, PD; Fusar-Poli, P; Martin-Santos, R; Borgwardt, S; Winton-Brown, T; Nosarti, C; O'Carroll, CM; Seal, M; Allen, P; Mehta, MA; Stone, JM; Tunstall, N; Giampietro, V; Kapur, S; Murray, RM; Zuardi, AW; Crippa, JA; Atakan, Z; McGuire, PK 2010; 35
Crippa, JA; Derenusson, GN; Ferrari, TB; Wichert-Ana, L; Duran, FL; Martin-Santos, R; Simões, MV; Bhattacharyya, S; Fusar-Poli, P; Atakan, Z; Santos Filho, A; Freitas-Ferrari, MC; McGuire, PK; Zuardi, AW; Busatto, GF; Hallak, JE 2011; 25
Grewal, JK; Loh, LC 2020; 192
Sarkadi, A; Vég, A; Rosenqvist, U 2005; 58
Parmar, JR; Forrest, BD; Freeman, RA 2016; 12
Opitz, BJ; Ostroff, ML; Whitman, AC 2020; 33
Vyas, MB; LeBaron, VT; Gilson, AM 2018; 66
Koren, DE; Zuckerman, A; Teply, R; Nabulsi, NA; Lee, TA; Martin, MT 2019; 6
Dunn, SP; Birtcher, KK; Beavers, CJ; et, al 2015; 66
Broyd, SJ; van Hell, HH; Beale, C; Yücel, M; Solowij, N 2016; 79
Fearon, J
Russo, EB 2017; 38
Joshi, M; Joshi, A; Bartter, T 2014; 20
Balneaves, LG; Alraja, A; Ziemianski, D; McCuaig, F; Ware, M 2018; 3
Zuardi, AW; Crippa, JA; Hallak, JE 2009; 23
Sarkadi, A; Rosenqvist, U 2004; 53
El-Ibiary, SY; Raney, EC; Moos, MK 2014; 54
Zehra, A; Burns, J; Liu, CK; Manza, P; Wiers, CE; Volkow, ND; Wang, GJ 2018; 13
Russo, EB 2011; 163
Mudan, A; DeRoos, F; Perrone, J 2019; 381
Ward, KE; Cohen, LB 2015; 30
Richards, JR 2018; 54
Vandrey, R; Herrmann, ES; Mitchell, JM; Bigelow, GE; Flegel, R; LoDico, C; Cone, EJ 2017; 41
Kempker, JA; Honig, EG; Martin, GS 2015; 12
Hunault, CC; van Eijkeren, JC; Mensinga, TT; de Vries, I; Leenders, ME; Meulenbelt, J 2010; 246
References_xml – volume: 23
  start-page: 979
  issue: 8
  year: 2009
  end-page: 983
  article-title: Cannabidiol for the treatment of psychosis in Parkinson's disease
  publication-title: J Psychopharmacol
  contributor:
    fullname: Zuardi, AW; Crippa, JA; Hallak, JE
– volume: 21
  start-page: 416
  issue: 4
  year: 2016
  end-page: 421
  article-title: Effects on Deaf Patients of Medication Education by Pharmacists
  publication-title: J Deaf Stud Deaf Educ
  contributor:
    fullname: Hyoguchi, N; Kobayashi, D; Kubota, T; Shimazoe, T
– volume: 122
  start-page: 205
  issue: 3
  year: 2018
  end-page: 209
  article-title: The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018
  publication-title: Health Policy
  contributor:
    fullname: Cox, C
– volume: 187
  start-page: 865
  issue: 12
  year: 2015
  end-page: 866
  article-title: Private cannabis clinics offer clients access
  publication-title: CMAJ
  contributor:
    fullname: Lough, S
– publication-title: Labeling problems have led to errors
– volume: 54
  start-page: e288
  issue: 5
  year: 2014
  end-page: e303
  article-title: The pharmacist's role in promoting preconception health
  publication-title: J Am Pharm Assoc (2003)
  contributor:
    fullname: El-Ibiary, SY; Raney, EC; Moos, MK
– volume: 70
  start-page: 435
  issue: 6
  year: 2017
  end-page: 442
  article-title: Impact of Pharmacists in a Community-Based Home Care Service:A Pilot Program
  publication-title: Can J Hosp Pharm
  contributor:
    fullname: Walus, AN; Woloschuk, DMM
– volume: 66
  start-page: 56
  issue: 1
  year: 2018
  end-page: 65
  article-title: The use of cannabis in response to the opioid crisis:A review of the literature
  publication-title: Nurs Outlook
  contributor:
    fullname: Vyas, MB; LeBaron, VT; Gilson, AM
– volume: 20
  start-page: 173
  issue: 2
  year: 2014
  end-page: 179
  article-title: Marijuana and lung diseases
  publication-title: Curr Opin Pulm Med
  contributor:
    fullname: Joshi, M; Joshi, A; Bartter, T
– volume: 12
  start-page: 638
  issue: 4
  year: 2016
  end-page: 654
  article-title: Medical marijuana patient counseling points for health care professionals based on trends in the medical uses efficacy, and adverse effects of cannabis-based pharmaceutical drugs
  publication-title: Res Social Adm Pharm
  contributor:
    fullname: Parmar, JR; Forrest, BD; Freeman, RA
– volume: 20
  start-page: 977
  issue: 1
  year: 2020
  article-title: The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer
  publication-title: BMC Health Serv Res
  contributor:
    fullname: Hawley, P; Gobbo, M; Afghari, N
– volume: 12
  start-page: 135
  issue: 2
  year: 2015
  end-page: 141
  article-title: The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the US. National Health and Nutrition Examination Study
  publication-title: Ann Am Thorac Soc
  contributor:
    fullname: Kempker, JA; Honig, EG; Martin, GS
– volume: 79
  start-page: 557
  issue: 7
  year: 2016
  end-page: 567
  article-title: Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review
  publication-title: Biol Psychiatry
  contributor:
    fullname: Broyd, SJ; van Hell, HH; Beale, C; Yücel, M; Solowij, N
– volume: 77
  start-page: 1044
  issue: 10
  year: 2020
  end-page: 1051
  article-title: Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence
  publication-title: JAMA Psychiatry
  contributor:
    fullname: Hines, LA; Freeman, TP; Gage, SH; Zammit, S; Hickman, M; Cannon, M; Munafo, M; MacLeod, J; Heron, J
– publication-title: Medical document supporting the use of cannabis for medical purposes under the cannabis regulations
– volume: 13
  start-page: 438
  issue: 4
  year: 2018
  end-page: 452
  article-title: Cannabis Addiction and the Brain:a Review
  publication-title: J Neuroimmune Pharmacol
  contributor:
    fullname: Zehra, A; Burns, J; Liu, CK; Manza, P; Wiers, CE; Volkow, ND; Wang, GJ
– volume: 54
  start-page: 354
  issue: 3
  year: 2018
  end-page: 363
  article-title: Cannabinoid Hyperemesis Syndrome:Pathophysiology and Treatment in the Emergency Department
  publication-title: J Emerg Med
  contributor:
    fullname: Richards, JR
– volume: 19
  start-page: 410
  issue: 5
  year: 2010
  end-page: 416
  article-title: Efficacy of motivational interviewing for smoking cessation:a systematic review and meta-analysis
  publication-title: Tob Control
  contributor:
    fullname: Heckman, CJ; Egleston, BL; Hofmann, MT
– volume: 72
  start-page: 487
  issue: 6
  year: 2015
  end-page: 492
  article-title: Pharmacist provision of patient medication education groups
  publication-title: Am J Health Syst Pharm
  contributor:
    fullname: Goldstone, LW; Saldaña, SN; Werremeyer, A
– publication-title: Tri-council policy statement:ethical conduct for research involving humans
– volume: 246
  start-page: 148
  issue: 3
  year: 2010
  end-page: 153
  article-title: Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content:a kinetic model
  publication-title: Toxicol Appl Pharmacol
  contributor:
    fullname: Hunault, CC; van Eijkeren, JC; Mensinga, TT; de Vries, I; Leenders, ME; Meulenbelt, J
– publication-title: Access to cannabis for medical purposes regulations
– volume: 6
  start-page: ofz316
  issue: 7
  year: 2019
  article-title: Expanding Hepatitis C Virus Care and Cure:National Experience Using a Clinical Pharmacist-Driven Model
  publication-title: Open Forum Infect Dis
  contributor:
    fullname: Koren, DE; Zuckerman, A; Teply, R; Nabulsi, NA; Lee, TA; Martin, MT
– article-title: Reasonable Doubt:the history of marijuana law in Canada
  publication-title: Now Magazine
  contributor:
    fullname: Fearon, J
– volume: 38
  start-page: 198
  issue: 3
  year: 2017
  end-page: 201
  article-title: Cannabidiol Claims and Misconceptions
  publication-title: Trends Pharmacol Sci
  contributor:
    fullname: Russo, EB
– volume: 66
  start-page: 2129
  issue: 19
  year: 2015
  end-page: 2139
  article-title: The role of the clinical pharmacist in the care of patients with cardiovascular disease
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Dunn, SP; Birtcher, KK; Beavers, CJ; et, al
– volume: 11
  start-page: e5806
  issue: 9
  year: 2019
  article-title: The Public Health Concerns of Marijuana Legalization:An Overview of Current Trends
  publication-title: Cureus
  contributor:
    fullname: Zvonarev, V; Fatuki, TA; Tregubenko, P
– volume: 21
  start-page: 417S
  issue: S1
  year: 1981
  end-page: 427S
  article-title: Hypnotic and antiepileptic effects of cannabidiol
  publication-title: J Clin Pharmacol
  contributor:
    fullname: Carlini, EA; Cunha, JM
– volume: 41
  start-page: 83
  issue: 2
  year: 2017
  end-page: 99
  article-title: Pharmacokinetic Profile of Oral Cannabis in Humans:Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes
  publication-title: J Anal Toxicol
  contributor:
    fullname: Vandrey, R; Herrmann, ES; Mitchell, JM; Bigelow, GE; Flegel, R; LoDico, C; Cone, EJ
– volume: 36
  start-page: 559
  year: 2015
  end-page: 574
  article-title: The prescription opioid and heroin crisis:a public health approach to an epidemic of addiction
  publication-title: Annu Rev Public Health
  contributor:
    fullname: Kolodny, A; Courtwright, DT; Hwang, CS; Kreiner, P; Eadie, JL; Clark, TW; Alexander, GC
– volume: 191
  start-page: E907
  issue: 33
  year: 2019
  end-page: E908
  article-title: Medical cannabis:strengthening evidence in the face of hype and public pressure
  publication-title: CMAJ
  contributor:
    fullname: Fitzcharles, MA; Shir, Y; Häuser, W
– publication-title: Statistics Canada. Data on cannabis for medical purposes
– publication-title: Pharmacists disappointed with proposed cannabis regulations, concerned with impact to medical cannabis patients
– volume: 33
  start-page: 506
  issue: 4
  year: 2020
  end-page: 512
  article-title: The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer
  publication-title: J Pharm Pract
  contributor:
    fullname: Opitz, BJ; Ostroff, ML; Whitman, AC
– volume: 31
  start-page: 569
  issue: 5
  year: 2017
  end-page: 575
  article-title: Substitution of medical cannabis for pharmaceutical agents for pain anxiety, and sleep
  publication-title: J Psychopharmacol
  contributor:
    fullname: Piper, BJ; DeKeuster, RM; Beals, ML; Cobb, CM; Burchman, CA; Perkinson, L; Lynn, ST; Nichols, SD; Abess, AT
– publication-title: Cannabis Act (S.C. 2018, c16)
– volume: 163
  start-page: 1344
  issue: 7
  year: 2011
  end-page: 1364
  article-title: Taming THC:potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
  publication-title: Br J Pharmacol
  contributor:
    fullname: Russo, EB
– volume: 35
  start-page: 764
  issue: 3
  year: 2010
  end-page: 774
  article-title: Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
  publication-title: Neuropsychopharmacology
  contributor:
    fullname: Bhattacharyya, S; Morrison, PD; Fusar-Poli, P; Martin-Santos, R; Borgwardt, S; Winton-Brown, T; Nosarti, C; O'Carroll, CM; Seal, M; Allen, P; Mehta, MA; Stone, JM; Tunstall, N; Giampietro, V; Kapur, S; Murray, RM; Zuardi, AW; Crippa, JA; Atakan, Z; McGuire, PK
– volume: 30
  start-page: 616
  issue: 10
  year: 2015
  end-page: 622
  article-title: Promoting Safe Use of Medications:Providing Medication Education to Seniors Receiving Meals on Wheels
  publication-title: Consult Pharm
  contributor:
    fullname: Ward, KE; Cohen, LB
– publication-title: Marihuana for medical purposes regulations, SOR/2013-119
– volume: 14
  start-page: 58
  issue: 1
  year: 2017
  article-title: Rationale for cannabis-based interventions in the opioid overdose crisis
  publication-title: Harm Reduct J
  contributor:
    fullname: Lucas, P
– volume: 318
  start-page: 347
  issue: 6
  year: 1988
  end-page: 351
  article-title: Pulmonary hazards of smoking marijuana as compared with tobacco
  publication-title: N Engl J Med
  contributor:
    fullname: Wu, TC; Tashkin, DP; Djahed, B; Rose, JE
– volume: 61
  start-page: 850
  issue: 6
  year: 2015
  end-page: 869
  article-title: Controlled Cannabis Vaporizer Administration:Blood and Plasma Cannabinoids with and without Alcohol
  publication-title: Clin Chem
  contributor:
    fullname: Hartman, RL; Brown, TL; Milavetz, G; Spurgin, A; Gorelick, DA; Gaffney, G; Huestis, MA
– volume: 25
  start-page: 121
  issue: 1
  year: 2011
  end-page: 130
  article-title: Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder:a preliminary report
  publication-title: J Psychopharmacol
  contributor:
    fullname: Crippa, JA; Derenusson, GN; Ferrari, TB; Wichert-Ana, L; Duran, FL; Martin-Santos, R; Simões, MV; Bhattacharyya, S; Fusar-Poli, P; Atakan, Z; Santos Filho, A; Freitas-Ferrari, MC; McGuire, PK; Zuardi, AW; Busatto, GF; Hallak, JE
– volume: 53
  start-page: 291
  issue: 3
  year: 2004
  end-page: 298
  article-title: Experience-based group education in Type 2 diabetes:a randomised controlled trial
  publication-title: Patient Educ Couns
  contributor:
    fullname: Sarkadi, A; Rosenqvist, U
– volume: 42
  start-page: 327
  issue: 4
  year: 2003
  end-page: 360
  article-title: Pharmacokinetics and pharmacodynamics of cannabinoids
  publication-title: Clin Pharmacokinet
  contributor:
    fullname: Grotenhermen, F
– volume: 76
  start-page: 270
  year: 2018
  end-page: 274
  article-title: Changing social norms:The impact of normative feedback included in motivational enhancement therapy on cannabis outcomes among heavy-using adolescents
  publication-title: Addict Behav
  contributor:
    fullname: Blevins, CE; Walker, DD; Stephens, RS; Banes, KE; Roffman, RA
– volume: 136
  start-page: 894
  issue: 4
  year: 2015
  end-page: 903
  article-title: Cannabis smoking and lung cancer risk:Pooled analysis in the International Lung Cancer Consortium
  publication-title: Int J Cancer
  contributor:
    fullname: Zhang, LR; Morgenstern, H; Greenland, S; Chang, SC; Lazarus, P; Teare, MD; Woll, PJ; Orlow, I; Cox, B; Brhane, Y; Liu, G; Hung, RJ
– volume: 44
  start-page: 57
  issue: 1
  year: 2007
  end-page: 64
  article-title: Interactive small-group asthma education in the community pharmacy setting:a pilot study
  publication-title: J Asthma
  contributor:
    fullname: Kritikos, V; Armour, CL; Bosnic-Anticevich, SZ
– volume: 3
  start-page: 66
  issue: 1
  year: 2018
  end-page: 73
  article-title: A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes
  publication-title: Cannabis Cannabinoid Res
  contributor:
    fullname: Balneaves, LG; Alraja, A; Ziemianski, D; McCuaig, F; Ware, M
– volume: 58
  start-page: 137
  issue: 2
  year: 2005
  end-page: 145
  article-title: The influence of participant's self-perceived role on metabolic outcomes in a diabetes group education program
  publication-title: Patient Educ Couns
  contributor:
    fullname: Sarkadi, A; Vég, A; Rosenqvist, U
– volume: 62
  start-page: 1615
  issue: 6
  year: 2017
  end-page: 1620
  article-title: Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease a Randomized Controlled Trial
  publication-title: Dig Dis Sci
  contributor:
    fullname: Naftali, T; Mechulam, R; Marii, A; Gabay, G; Stein, A; Bronshtain, M; Laish, I; Benjaminov, F; Konikoff, FM
– volume: 6
  start-page: 5
  issue: 1
  year: 2019
  end-page: 6
  article-title: Cannabis legalisation in Canada:a crucial trial balloon
  publication-title: Lancet Psychiatry
  contributor:
    fullname: Hill, KP; George, TP
– volume: 64
  start-page: 1037
  issue: 10
  year: 2007
  end-page: 1044
  article-title: Medical marijuana and the developing role of the pharmacist
  publication-title: Am J Health Syst Pharm
  contributor:
    fullname: Seamon, MJ; Fass, JA; Maniscalco-Feichtl, M; Abu-Shraie, NA
– volume: 192
  start-page: E1
  issue: 1
  year: 2020
  end-page: E2
  article-title: Health considerations of the legalization of cannabis edibles
  publication-title: CMAJ
  contributor:
    fullname: Grewal, JK; Loh, LC
– volume: 168
  start-page: 187
  issue: 3
  year: 2018
  end-page: 194
  article-title: Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes:A Systematic Review
  publication-title: Ann Intern Med
  contributor:
    fullname: Ravi, D; Ghasemiesfe, M; Korenstein, D; Cascino, T; Keyhani, S
– volume: 152
  start-page: 14
  issue: 1
  year: 2018
  end-page: 15
  article-title: Pharmacists' role in cannabis dispensing and counselling
  publication-title: Can Pharm J (Ott)
  contributor:
    fullname: Dattani, S; Mohr, H
– volume: 381
  start-page: 1086
  issue: 11
  year: 2019
  end-page: 1087
  article-title: Medical Marijuana Miscalculation
  publication-title: N Engl J Med
  contributor:
    fullname: Mudan, A; DeRoos, F; Perrone, J
SSID ssib055682418
ssib044755940
ssj0068610
Score 2.2353582
Snippet The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of...
Objective: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits...
OBJECTIVEThe primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and...
SourceID doaj
dialnet
scielo
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2088
SubjectTerms Canada
Cannabis
Chronic Pain
Educational Measurement
Medical Marijuana
Original Research
Patient Education as Topic
Patient Preference
Pharmacists
Pharmacology & Pharmacy
Surveys and Questionnaires
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYltNBLadOX-wgKlPQSN7Ik63FsS0MIpCw0gb0JS5bohtQb4t1D_n1nLO-LFnrpzUiWH5rPmm-k8SdCPiTPg4y1L0VjTSmrKpbeJFFWdZOiaAEEw1T2xXd1diXPp_V0a6svzAnL8sC54058ExobamNSTNJbYWJMrQlwEIIB_jCMvsxuBVOAJFSxq7eE4VBmC1zVen1BGZV1Cgym3ks-HTO_DERLJxPUjB7UgiB85OwTzrwMG7Ns_NYj_Kmji4tR6P9v7PTPJMuH6NNutt3X6VPyZOSd9HN-32fkQez2ydEkC1ffH9PLzX9Y_TE9opONpPX9czK5wAkHXI-nt7kC0FHexJbGVYII7bPCBwUWTEe11h4KI87F0195PYiCIbvGz_oX5Or02-XXs3Lci6EMQOgWJfCyBFblKnhhW8FYMMnYyqjkE1feKJaqAD0ejU9KcOs1nJp8xSPXNshWvCR73byLrwkNSrZVG21T2ygDkz4ASTI6aqaVtrwtCFv1tLvNkhsOQxU0jtsYx6FxnHRonILUo0XWLVA2e1W27GZ3s_l142LvIEwY4kIJ1JEV5Avab7cRFgAC3YhA9y8EFuRwZX0H3yYuuDRdnC97x8Hz1wIIqS7Iq4yG9a2EgAqtq4LoHZzsPMtuTTf7Oeh_aw2jcAUtP2ZEuXHY6d0PBLRDQGPnsGGEBpL35n-85lvyGC-aExnfkb3F3TK-B0K28AfDt_cbHOMyEA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66Kvgi3q03Isj6sl3bJs3lQUTFZRFWBtyBeQtNmujI2FmnM-D8e89p2hmLiw--laRpS75zmu8kJ18IeRls4bgvbcoqrVKe5z61KrA0L6vgWQ1G0E1ln30Wp1P-aVbO9jvr-g5sLw3t8Dyp6Wpx_Ovn9i04_Bt0eAXxzesJqjx3-j4Q8BXZMc6VKHWVXCtwPxDm8_Hd0oJQIkoUKCVSJsqyT_r6x4NGQ9YN3M_R-HWv8X8ZMf07v_I6DmeLP0euk9vkVk856btoI3fIFd_cJYeTqFm9PaLn-y1Y7RE9pJO9mvX2Hpmc4VwDLsXTi1gBhpEufE39kBtC2yjuQYEA016otYVCj9Pw9EdcCqKAYVPZeXufTE8-nn84TftjGFIHXG6dAiULAGghnGW6ZlnmVFA6VyLYUAirRBZyp3nmlQ2CFdpKuDXYvPCF1I7X7AE5aJaNf0SoE7zOa6-rUnvuMm4d8CMlvcykkLqoE5INPW0uotqGwSgFwTF7cAyCY7hBcBJS9ojsWqBi9lC2aear-fJ7ZXxrIELoQkIOrDFLyHvEb9wIC5arr6b3WmASrtKuVCr4wK1myvtQKwcXzikgrwl5MaBvwC1xraVq_HLTmgIG_ZIBF5UJeRitYfcqxqBCyjwhcmQno28Z1zTzb530t5TwA86h5atoUWZwGPMFDLo0EE3OsHOy7ucM_O7xf3bPE3ITnxPTFp-Sg_Vq458B_Vrb5507_QYm5zAC
  priority: 102
  providerName: Scholars Portal
Title Mandatory pharmacist-led education session for patients seeking medical cannabis
URI https://www.ncbi.nlm.nih.gov/pubmed/33343771
https://search.proquest.com/docview/2471534357
https://pubmed.ncbi.nlm.nih.gov/PMC7732211
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2020000400008&lng=en&tlng=en
https://dialnet.unirioja.es/servlet/oaiart?codigo=7843903
https://doaj.org/article/baca9c588fef4b938eefd8c938cc8083
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBa7Swu9lL7rPhYVyvayTmxLluRju-yyFFIM3YXchCVLrUvihDg57KW_vTN-JGvaUy8myHZsaz55vhmNPhPy0ZvEcpeakBWZCnkcu9Aoz8I4LbxjJYCgTWXPvonrW_51ns6PSDqshWmL9q2pJvViOamrn21t5Xppp0Od2DSfXUgJMIzj6TE5BoCOQ3QUsEvvacKhwhZ4qf3UglCikyhQWHXPk3lf9KUgUJrmKBfdCgVB5JhEE0y6KPykH2OMMynjkfd6iEs7arft5f7_xVH_LrV8gJ5tcd-JXT0hj3v2ST93T_mUHLn6GTnLO_nqu3N6c1iN1ZzTM5ofhK3vnpN8hmkHnJWn624HYCRcuJK6oUyENp3OBwUuTHvN1gYaHWbk6bKbFaJgzrowVfOC3F5d3lxch_0XGUILtG4bAjvzYNtEWMOykkWRVV5lsRLe-EQYJSIfW-h8p4wXLMmMhEO9iROXyMzykr0kJ_Wqdq8JtYKXcemyIs0ctxE3FqiSkk5GUsgsKQMSDT2t153whsaABe2kD3bSaCfNNdopIGlvkf0ZKJ49tO3qalOtfhXaNRqChTY65EAgo4B8QfuNT8KG1eaH7nEHpMIWmU2V8s5zkzHlnC-VhR_WKuCxAfkwWF_DCMVpl6J2q12jE_D_KcAnlQF51aFhf6kBVwGRI5yM7mW8BwZFqwLeD4KAfOoQpfuXT6O_I7Y1Yhs7J2rf00D13vz3Nd6SR_hPXQ3jO3Ky3ezce-BiW3Pa5jBgO-MKt78vT9vR-AdPHDOc
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24331,27937,27938,53805,53807
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGAMEL90u4GgmNl6VNYid2HmFiKrBOlehQ36zYsVlHm1ZN-zB-Pefk0i7AC7xVdtNE9nd6vmN__kLIW6cjw22sfZal0udhaH0tHfPDOHOW5QCCail7eJoMzvjnSTzZI3F7FqYS7Rs97RWzea-YnlfayuXc9FudWH80PBICYBiG_WvkOsRrEHeLdLSwi6-4wqHHFuSp7eZCIpPapECi7p5Hk0b2JaFU6o_QMLqyCoLaMQp6uOwi8aV-jDHOhAg7-esmHu4o7Lox_P8bS_1TbHkDc9vsaho7vku-tQNQq1d-9DZr3TM_f_OG_OcRukfuNMSWvq-775M9WzwgB6PaGfvykI53B73KQ3pARzvP7MuHZDTEFQ3c8KfLugPg589sTm2rQKFlbSFCgWbTxg62hEaLi_10Xm84UUBKkelp-YicHX8cHw385mUPvgHGuPaB-DmATZQYzdKcBYGRTqahTJx2UaJlErjQwKxaqV3ColQL-KrTYWQjkRqes8dkv1gU9imhJuF5mNs0i1PLTcC1ARYmhRWBSEQa5R4J2ilUy9rTQ2EthABQOwAoBIDiCgHgkbiZ6u0V6Mvdtm2K6Wq6uMiULRXUIVXhyYGbBh75gMDoXoQNi9V31UwY8BWTpSaW0lnHdcqktS6XBj4YI4Eie-RNCysFwY87OllhF5tSRUAtYsBlLDzypIbZ9lYtYD0iOgDsPEu3B9BUGYw36PHIuxqqqvlfK9VXDBqFQYODE1QpAFjks_--x2tyazAenqiTT6dfnpPb-Ku1VPIF2V-vNvYlUL61flUF-C820FKK
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jj9MwGLVgWMSFfQmrkdBwmbRJ7MTOEQaqYekoEjPSaC5W7NhQaNOqaQ_Dr-f7srQNcJpb5DiL7Od877Nfngl543RkuI21z_JU-jwMra-lY34Y586yAkBQT2WPj5OjU_75LD7b2eqrFu0bPRmU09mgnPyotZWLmRl2OrFhNj4UAmAYhsNF4YZXybUYTdP7iTra2MU7znDoswWxarPAkMikMSqQqL3n0Vkr_ZKQLg0zNI2u7YIgf4yCAU69SNzYjzHGmRBhL4bdwB88SrtqTf__x1T_FVxex_g23Q1lozvkvGuERsHya7Be6YH5_Zc_5KVa6S653RJc-q6pco9cseV9sp81DtkXB_Rk-8NXdUD3abb1zr54QLIxzmzgwj9dNCcAhv7UFtR2ShRaNVYiFOg2bW1hKyi0OOlPZ83CEwXElLmeVA_J6ejjyeGR32764BtgjisfCKAD-ESJ0SwtWBAY6WQaysRpFyVaJoELDfSsldolLEq1gKpOh5GNRGp4wR6RvXJe2ieEmoQXYWHTPE4tNwHXBtiYFFYEIhFpVHgk6LpRLRpvD4U5EYJAbUGgEASKKwSBR-K2uzdXoD93V7YuJ8vJ_GeubKUgH6kTUA4cNfDIewRH_yIsmC-_q7bTgLeYPDWxlM46rlMmrXWFNHBgjASq7JHXHbQUfARwZScv7XxdqQgoRgzYjIVHHjdQ2zyqA61HRA-EvXfpnwFE1UbjLYI88raBq2q_b5X6hgNH4cDBxgnqUABs8umln_GK3Mw-jNTXT8dfnpFbeNNGMfmc7K2Wa_sCmN9Kv6zH-B-6g1UK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mandatory+pharmacist-led+education+session+for+patients+seeking+medical+cannabis&rft.jtitle=Pharmacy+practice&rft.au=Parihar%2C+Vikas&rft.au=Katz%2C+Laura&rft.au=Siyam%2C+Mahmoud+A&rft.au=Rogers%2C+Anna&rft.date=2020-10-01&rft.issn=1885-642X&rft.volume=18&rft.issue=4&rft.spage=2088&rft.epage=2088&rft_id=info:doi/10.18549%2FPharmPract.2020.4.2088&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1885-642X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1885-642X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1885-642X&client=summon